1
|
Wu JL, Yang SL, Ho YC, Chen CH, Tasi BR, Lee MC, Chen BY. The Functional Vision Restorative Effect of Crocin via the BDNF-TrkB Pathway: An In Vivo Study. Nutrients 2022; 14:nu14091716. [PMID: 35565684 PMCID: PMC9100189 DOI: 10.3390/nu14091716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2022] [Revised: 04/13/2022] [Accepted: 04/19/2022] [Indexed: 12/10/2022] Open
Abstract
Abnormal dislocation of cone opsin protein affects the sensitivity function of photoreceptors and results in depressed central vision. Nutraceutical therapy is needed to restore the residual function of photoreceptors. Crocin is a natural substance for retinal health. However, its effect on the restoration of functional vision and its underlying mechanisms have not been fully studied. This study analyzed the restorative effect of crocin on residual functional vision in vivo in a mouse model. High-energy light-evoked photoreceptor dysfunction was confirmed by M opsin dislocation in the retina accompanied by a loss of functional vision. Crocin treatment significantly increased brain-derived neurotrophic factor (BDNF) protein in retinas, thus contributing to the re-localization of the M opsin protein, restoration of the visual acuity (VA), and high spatial frequency-characterized visual contrast sensitivity function (VCSF). In contrast, such effects were significantly reversed after the washout period. Additionally, the restorative effect of crocin on functional vision and M opsin re-localization can be reversed and blocked by synchronous injection of a tropomyosin receptor kinase B (TrkB) receptor antagonist (ANA-12). This study demonstrated the major functional vision-rescuing or restoring effect of crocin in vivo by modulating M opsin location plasticity and increasing the capacity of the residual photoreceptor function through the BDNF-TrkB receptor pathway.
Collapse
Affiliation(s)
- Jia-Lain Wu
- Department of Optometry, Chung Shan Medical University, Taichung 40201, Taiwan; (J.-L.W.); (B.-R.T.)
| | - Shih-Liang Yang
- Department of Chinese Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung 40343, Taiwan;
| | - Yung-Chuan Ho
- Department of Medical Applied Chemistry, Chung Shan Medical University, Taichung City 40201, Taiwan;
- Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
| | - Chao-Hsiang Chen
- Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 11031, Taiwan;
- Ko Da Pharmaceutical Co., Ltd., Taoyuan 32459, Taiwan
| | - Bing-Rong Tasi
- Department of Optometry, Chung Shan Medical University, Taichung 40201, Taiwan; (J.-L.W.); (B.-R.T.)
| | - Meng-Chih Lee
- Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan;
- Institute of Population Health Sciences, National Health Research Institutes, Miaoli 35053, Taiwan
| | - Bo-Yie Chen
- Department of Optometry, Chung Shan Medical University, Taichung 40201, Taiwan; (J.-L.W.); (B.-R.T.)
- Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
- Correspondence: ; Tel.: +886-4-2473-0022 (ext. 12319); Fax: +886-4-2324-8131
| |
Collapse
|